Open AccessCardiovascular imaging in the acute phase of coronavirus disease 2019 (COVID-19)
Author(s) -
Wioletta Sacharczuk,
R. Dankowski,
Anna Marciniak,
Anna Szałek-Goralewska,
Andrzej Szyszka
Publication year - 2021
Publication title -
journal of medical science
Language(s) - English
Resource type - Journals
eISSN - 2353-9801
pISSN - 2353-9798
DOI - 10.20883/medical.e532
Subject(s) - medicine , intensive care medicine , pulmonary embolism , pandemic , cardiology , myocarditis , cardiac tamponade , disease , covid-19 , acute myocarditis , heart failure , acute pericarditis , pericarditis , infectious disease (medical specialty)
The coronavirus disease 2019 (COVID-19) has become the most critical healthcare issue worldwide since the pandemic was announced in March 2020. Although respiratory symptoms remain the critical characteristic feature of COVID-19 (with acute respiratory syndrome as the leading cause of mortality), the disease also affects other organs. In fact, the involvement of the cardiovascular system during COVID-19 may include acute coronary symptoms, acute heart failure and myocarditis, arrhythmias, cardiac tamponade, pulmonary embolism, and right ventricular failure due to a high-pressure mechanical ventilation. It is vital to note that all of the abovementioned disorders require specific, pandemic-adapted imaging algorithms.This brief review aims to discuss different cardiac imaging modalities to demonstrate their effectiveness in managing patients in the acute phase of COVID-19.